Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Psychiatry. 1994 May;151(5):756-9.

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients.

Author information

1
Camarillo-UCLA Research Center, Camarillo State Hospital, CA 93011-6022.

Abstract

Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.

PMID:
8166320
DOI:
10.1176/ajp.151.5.756
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center